A cost-effectiveness analysis of denosumab for the prevention of skeletal-related events in patients with multiple myeloma in the United States of America

Journal of Medical Economics
Noopur RajeGuy Hechmati

Abstract

A large, pivotal, phase 3 trial in patients with newly diagnosed multiple myeloma (MM) demonstrated that denosumab, compared with zoledronic acid, was non-inferior for the prevention of skeletal-related events (SREs), extended the observed median progression-free survival (PFS) by 10.7 months, and showed significantly less renal toxicity. The cost-effectiveness of denosumab vs zoledronic acid in MM in the US was assessed from societal and payer perspectives. The XGEVA Global Economic Model was developed by integrating data from the phase 3 trial comparing the efficacy of denosumab with zoledronic acid for the prevention of SREs in MM. SRE rates were adjusted to reflect the real-world incidence. The model included utility decrements for SREs, administration, serious adverse events (SAEs), and disease progression. Drug, administration, SRE management, SAEs, and anti-MM treatment costs were based on data from published studies. For the societal perspective, the model additionally included SRE-related direct non-medical costs and indirect costs. The net monetary benefit (NMB) was calculated using a willingness-to-pay threshold of US$150,000. One-way deterministic and probabilistic sensitivity analyses were conducted. From a societa...Continue Reading

References

Feb 1, 1966·The Journal of Laryngology and Otology·P M Binns, H D Fairman
Oct 16, 1996·JAMA : the Journal of the American Medical Association·M C WeinsteinL B Russell
Jul 30, 2003·Archives of Internal Medicine·Peter A UbelA Mark Fendrick
Mar 9, 2004·Blood Cells, Molecules & Diseases·G David Roodman
Apr 28, 2004·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M van AgthovenP Sonneveld
Mar 30, 2007·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Ingo J Diel
Jun 5, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Cesare GridelliCristina Negrini
Feb 20, 2008·PharmacoEconomics·Kate McKeage, Greg L Plosker
Aug 7, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Roger von MoosKathrin Zaugg
Jun 18, 2010·The Journal of Clinical Endocrinology and Metabolism·I R ReidD M Black
Mar 18, 2011·The New England Journal of Medicine·Antonio Palumbo, Kenneth Anderson
Mar 29, 2012·American Journal of Hematology·Henry J HenkSatyin Kaura
Sep 15, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Allan LiptonSusie Jun
Jan 29, 2013·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Louis S MatzaJean-Jacques Body
Mar 23, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Kaitlin KooEdward Chow
May 2, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R ColemanUNKNOWN ESMO Guidelines Working Group
Aug 28, 2014·The New England Journal of Medicine·Peter J NeumannMilton C Weinstein
Sep 5, 2014·Cancer Growth and Metastasis·Abdul HameedPeter O'Gorman
Jan 27, 2015·Critical Reviews in Oncology/hematology·U RochauU Siebert
Mar 17, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Scott D RamseySean D Sullivan
Sep 4, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Roger von MoosYi Qian
Nov 22, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Athanasios Dellis, Athanasios Papatsoris
Jan 15, 2016·Mayo Clinic Proceedings·S Vincent Rajkumar, Shaji Kumar
Oct 5, 2016·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Claire WilliamsAndrew H Briggs

❮ Previous
Next ❯

Citations

Feb 15, 2019·Blood·Evangelos TerposMeletios A Dimopoulos
Oct 28, 2019·British Journal of Pharmacology·Silvia MarinoG David Roodman
Mar 28, 2020·Journal of the American Geriatrics Society·Russell K Portenoy
Jul 23, 2020·PharmacoEconomics·David D KimPeter J Neumann
Nov 30, 2020·British Journal of Haematology·Evangelos Terpos, Ioannis Ntanasis-Stathopoulos
Jan 28, 2021·Medical Sciences : Open Access Journal·Sandeep Anand PadalaGermame Hailegiorgis Ajebo
Feb 6, 2021·The Lancet Oncology·Evangelos TerposUNKNOWN Bone Working Group of the International Myeloma Working Group
Oct 13, 2021·Archives of Osteoporosis·Ben JohnsonBjörn Stollenwerk
Nov 6, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Michelle R SproatSteven Gilmore

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.